
Craig D. Ricci
Examiner (ID: 6907, Phone: (571)270-5864 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1611, 1628, 1614 |
| Total Applications | 1601 |
| Issued Applications | 776 |
| Pending Applications | 153 |
| Abandoned Applications | 697 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18149627
[patent_doc_number] => 20230023484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => DEPOT ADMINISTRATION OF ILOPERIDONE
[patent_app_type] => utility
[patent_app_number] => 17/935911
[patent_app_country] => US
[patent_app_date] => 2022-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17935911
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/935911 | DEPOT ADMINISTRATION OF ILOPERIDONE | Sep 26, 2022 | Abandoned |
Array
(
[id] => 20466613
[patent_doc_number] => 12522646
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-13
[patent_title] => Activin receptor type II chimeras and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/945299
[patent_app_country] => US
[patent_app_date] => 2022-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 51459
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17945299
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/945299 | Activin receptor type II chimeras and methods of use thereof | Sep 14, 2022 | Issued |
Array
(
[id] => 20848318
[patent_doc_number] => 12685331
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-07-21
[patent_title] => Nutritional compositions and infant formula for promoting de novo myealination
[patent_app_type] => utility
[patent_app_number] => 17/943652
[patent_app_country] => US
[patent_app_date] => 2022-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 67
[patent_no_of_words] => 20037
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17943652
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/943652 | NUTRITIONAL COMPOSITIONS AND INFANT FORMULA FOR PROMOTING DE NOVO MYEALINATION | Sep 12, 2022 | Issued |
Array
(
[id] => 20371265
[patent_doc_number] => 12478680
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => Hydrogels with biodegradable crosslinking
[patent_app_type] => utility
[patent_app_number] => 17/930381
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 11353
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 623
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930381
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930381 | Hydrogels with biodegradable crosslinking | Sep 6, 2022 | Issued |
Array
(
[id] => 18285418
[patent_doc_number] => 20230100890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => USE OF COMBINED INHALANT CANNABINOID THERAPY IN THE TREATMENT OF MIGRAINE
[patent_app_type] => utility
[patent_app_number] => 17/930218
[patent_app_country] => US
[patent_app_date] => 2022-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19801
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930218
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930218 | USE OF COMBINED INHALANT CANNABINOID THERAPY IN THE TREATMENT OF MIGRAINE | Sep 6, 2022 | Abandoned |
Array
(
[id] => 18108023
[patent_doc_number] => 20230000903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => METHODS AND SYSTEMS FOR NITRIC OXIDE THERAPY FOR THE TREATMENT OR PREVENTION OF RESPIRATORY INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/929511
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24805
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929511
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929511 | METHODS AND SYSTEMS FOR NITRIC OXIDE THERAPY FOR THE TREATMENT OR PREVENTION OF RESPIRATORY INFECTIONS | Sep 1, 2022 | Pending |
Array
(
[id] => 18451493
[patent_doc_number] => 20230192771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => CYCLOSPORINE COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/891351
[patent_app_country] => US
[patent_app_date] => 2022-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17194
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17891351
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/891351 | Cyclosporine compositions and methods of use | Aug 18, 2022 | Issued |
Array
(
[id] => 19526508
[patent_doc_number] => 20240350410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => FREEZE-DRYING OF LIPID NANOPARTICLES (LNPS) ENCAPSULATING RNA AND FORMULATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/683535
[patent_app_country] => US
[patent_app_date] => 2022-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18683535
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/683535 | FREEZE-DRYING OF LIPID NANOPARTICLES (LNPS) ENCAPSULATING RNA AND FORMULATIONS THEREOF | Aug 15, 2022 | Pending |
Array
(
[id] => 19380873
[patent_doc_number] => 20240270743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => TETRAHYDROPYRAZOLOPYRIDINE-ANALOG LIGANDS OF NLRX1 AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/682563
[patent_app_country] => US
[patent_app_date] => 2022-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18044
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18682563
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/682563 | TETRAHYDROPYRAZOLOPYRIDINE-ANALOG LIGANDS OF NLRX1 AND USES THEREOF | Aug 8, 2022 | Pending |
Array
(
[id] => 18250426
[patent_doc_number] => 20230077465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => LOW DOSE PRODUCT AND METHOD FOR TREATING DIARRHEA
[patent_app_type] => utility
[patent_app_number] => 17/884403
[patent_app_country] => US
[patent_app_date] => 2022-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5977
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17884403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/884403 | LOW DOSE PRODUCT AND METHOD FOR TREATING DIARRHEA | Aug 8, 2022 | Abandoned |
Array
(
[id] => 20067022
[patent_doc_number] => 20250205244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-26
[patent_title] => METHODS OF TREATING MIGRAINE WITH MNK INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/294823
[patent_app_country] => US
[patent_app_date] => 2022-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37646
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18294823
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/294823 | METHODS OF TREATING MIGRAINE WITH MNK INHIBITORS | Aug 4, 2022 | Pending |
Array
(
[id] => 20535712
[patent_doc_number] => 12552776
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-17
[patent_title] => Crystalline forms
[patent_app_type] => utility
[patent_app_number] => 18/291712
[patent_app_country] => US
[patent_app_date] => 2022-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 8970
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18291712
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/291712 | Crystalline forms | Jul 31, 2022 | Issued |
Array
(
[id] => 19541603
[patent_doc_number] => 20240358639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => NANOPARTICLES FOR CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/577129
[patent_app_country] => US
[patent_app_date] => 2022-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6853
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18577129
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/577129 | NANOPARTICLES FOR CANCER TREATMENT | Jul 6, 2022 | Abandoned |
Array
(
[id] => 18565584
[patent_doc_number] => 20230255911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => COMPOSITIONS OF BIOACTIVE FULVATE FRACTIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/810805
[patent_app_country] => US
[patent_app_date] => 2022-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810805
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810805 | COMPOSITIONS OF BIOACTIVE FULVATE FRACTIONS AND USES THEREOF | Jul 4, 2022 | Abandoned |
Array
(
[id] => 18374324
[patent_doc_number] => 20230149403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => CARBONIC ANHYDRASE ENZYMES FOR REGULATING MAST CELL HEMATOPOIESIS AND TYPE 2 INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 17/855501
[patent_app_country] => US
[patent_app_date] => 2022-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13363
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17855501
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/855501 | Carbonic anhydrase enzymes for regulating mast cell hematopoiesis and type 2 inflammation | Jun 29, 2022 | Issued |
Array
(
[id] => 17928250
[patent_doc_number] => 20220323375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY
[patent_app_type] => utility
[patent_app_number] => 17/853367
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5159
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17853367
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/853367 | USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY | Jun 28, 2022 | Abandoned |
Array
(
[id] => 17959994
[patent_doc_number] => 20220340574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => SOLID POLYMORPHS OF A FLNA-BINDING COMPOUND AND ITS HYDROCHLORIDE SALTS
[patent_app_type] => utility
[patent_app_number] => 17/850198
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17850198
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/850198 | Solid polymorphs of a FLNA-binding compound and its hydrochloride salts | Jun 26, 2022 | Issued |
Array
(
[id] => 18842475
[patent_doc_number] => 20230404879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => ENHANCING PHOTOSTABILITY OF THIOPYRIDINONE COMPOUND WITHOUT THE USE OF UV FILTERS
[patent_app_type] => utility
[patent_app_number] => 17/844934
[patent_app_country] => US
[patent_app_date] => 2022-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17844934
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/844934 | Enhancing photostability of thiopyridinone compound without the use of UV filters | Jun 20, 2022 | Issued |
Array
(
[id] => 17911471
[patent_doc_number] => 20220313866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => HYALURONIC ACID DERIVATIVE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/842475
[patent_app_country] => US
[patent_app_date] => 2022-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12894
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842475
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/842475 | HYALURONIC ACID DERIVATIVE AND USE THEREOF | Jun 15, 2022 | Abandoned |
Array
(
[id] => 21009835
[patent_doc_number] => 12746306
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-09-29
[patent_title] => Hyaluronic acid derivative and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/842493
[patent_app_country] => US
[patent_app_date] => 2022-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 73
[patent_no_of_words] => 7808
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842493
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/842493 | HYALURONIC ACID DERIVATIVE AND USE THEREOF | Jun 15, 2022 | Pending |